Mutism and Persistent Dysarthria Due to Tacrolimus-Based Immunosuppression Following Allogeneic Liver Transplantation

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Journal of Therapeutics

• Publication date

  2011-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MJT.0b013e3181debc6fPMID 20535006
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Catatonic mutism after liver transplant rapidly reversed with lorazepam.

  2007cited by this paper
• Tacrolimus (FK506)-induced mutism after liver transplant.

  2003cited by this paper
• Tacrolimus-associated mutism after orthotopic liver transplantation.

  2000cited by this paper
• Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantation.

  1999cited by this paper
• Dysarthria and apraxia of speech associated with FK-506 (tacrolimus).

  1996influential reference
• Loss of speech after orthotopic liver transplantation

  1995cited by this paper
• Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group.

  1994cited by this paper
• FK506‐induced neurotoxicity in liver transplantation

  1994cited by this paper
• Neurologic complications of FK 506.

  1991influential reference
• Similar clinical presentation of neurotoxicity following FK 506 and cyclosporine in a liver transplant recipient.

  1991cited by this paper
• Expessive dysphasia possibly related to FK506 in two liver transplant recipients

  1990cited by this paper
• Expressive dysphasia possibly related to FK506 in two liver transplant recipients.

  1990cited by this paper

• Tacrolimus-induced akinetic mutism and persistent dysarthria following orthotopic liver transplantation

  2023influential citation
• Catatonia in the Medically ILL: Etiology, Diagnosis, and Treatment. The Academy of Consultation-Liaison Psychiatry Evidence-Based Medicine Subcommittee Monograph

  2018cites this paper
• Late onset of progressive speech impairment due to tacrolimus-associated leukoencephalopathy after kidney transplantation

  2015cites this paper
• Catatonia in Medically Ill Patients An Evidence-Based Medicine ( EBM ) Monograph for Psychosomatic Medicine Practice

  2015cites this paper
• Chapter 81 – Neuropsychiatric Complications

  2015cites this paper
• Drugs that act on the immune system: Immunosuppressive and immunostimulatory drugs

  2014cites this paper
• Drugs that act on the immune system

  2014cites this paper
• Akinetic mutism—a serious complication to tacrolimus-based GVHD prophylaxis

  2013cites this paper
• Current World Literature

  2012cites this paper
• Calcineurin Inhibitor Encephalopathy

  2012cites this paper
• to optimize

  2012cites this paper